ScrutarSign up free

ALBEMARLE CORP (ALB)

SEC filings, insider trading & institutional ownership from EDGAR.

NYSEMaterialsChemicals

Albemarle Corporation is a specialty chemicals company that describes itself as a world leader in transforming essential resources into critical ingredients for mobility, energy, connectivity, and health. It was incorporated in Virginia in 1993 and is headquartered in Charlotte, North Carolina. The company and its joint ventures operate more than 25 production and research and development facilities worldwide, along with administrative and sales offices. It relies on proprietary process chemistry and R&D, and owned more than 1,500 active patents as of December 31, 2025.

During 2025 Albemarle reported three segments: Energy Storage, Specialties and Ketjen. Energy Storage develops and manufactures basic lithium compounds, including lithium carbonate, lithium hydroxide and lithium chloride. Specialties combines bromine and highly specialized lithium products. These include fire safety compounds, elemental bromine, alkyl bromides, inorganic bromides, butyllithium, lithium aluminum hydride, and cesium, zirconium, barium and titanium products. Ketjen offers clean fuels technologies (hydroprocessing, isomerization and alkylation catalysts), fluidized catalytic cracking catalysts and additives, and performance catalyst solutions (organometallics and curatives). In October 2025 the company agreed to divest the controlling interest in Ketjen's Refining Solutions business and contribute the remainder to a new partnership, Holdco, which is expected to close in the first quarter of 2026. It sold its 50% interest in Eurecat S.A. in January 2026. It will retain the PCS business and a 49% interest in Holdco.

As of December 31, 2025, Albemarle served about 1,900 customers in about 70 countries. End markets include grid storage, automotive, aerospace, conventional energy, electronics, construction, agriculture and food, and pharmaceuticals and medical devices. Lithium goes into batteries for electronics and electric vehicles, grids, solar panels, greases and specialty glass. Bromine and lithium specialties serve electronics, vehicles, pharmaceutical synthesis, and food and water safety. Ketjen catalysts serve oil refiners and polymer and resin producers. Sales rely on a strategic account program for large global customers, regional sales and technical staff, and sales representatives where needed. The company had about 7,800 employees at year-end 2025.

For lithium, Albemarle buys concentrate from its 49%-owned Windfield joint venture (owner of Talison and the Greenbushes mine) and its 50%-owned MARBL joint venture (Wodgina mine) in Western Australia. It also produces lithium by solar evaporation at the Salar de Atacama in Chile and at Silver Peak, Nevada, and holds mineral rights in Kings Mountain, North Carolina, and land in Antofalla, Argentina. Bromine comes from Arkansas and, through the 50%-owned Jordan Bromine Company, from the Dead Sea. Ketjen raw materials such as sodium silicate, kaolin, aluminum and metals are bought from numerous suppliers. Competitors in lithium include SQM, Sichuan Tianqi, Ganfeng, Rio Tinto, Pilbara Minerals and Tesla. In Specialties they include Lanxess, Israel Chemicals and Rio Tinto, and in Ketjen they include Shell Catalysts & Technologies, Advanced Refining Technologies, Haldor Topsoe, W.R. Grace, BASF, Nouryon and Arxada. The business is subject to chemical and environmental regulation such as REACH and TSCA.

AI-summarized from Item 1 (Business) of the company’s most recent 10-K filing.

RevenueFY2025
$5.14B
▼ 4.4%YoY
Net incomeFY2025
-$510.63M
▲ 56.7%YoY
Diluted EPSFY2025
-$5.76
▲ 48.6%YoY
Gross margin
13.0%
▲ 1184 bpsYoY
Insider net6 mo
+14.2K
shares1 sells0 buys
Institutions
53
$11.51B held

Financials

As reported to the SEC via XBRL, no adjustments

All financials →
Revenue & net income
-$2.5B$2.5B$5B$7.5B$10B
FY2022FY2023FY2024FY2025
RevenueNet income
FY2025 highlightsfrom 10-K
Gross profit$668.72M
Operating income-$367.08M
Diluted EPS-$5.76
Gross margin13.0%
Net margin-9.9%

Latest filings

10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR

All filings →
FormFiledAccession
8-KNov 4, 2026EDGAR
10-QNov 4, 2026EDGAR
8-KOct 30, 2026EDGAR
SC 13GFranklin Templeton, Inc. and 2 other reporting personsOct 28, 2026EDGAR
4Wolff Alejandro DanielOct 3, 2026EDGAR
4Norris EricSep 16, 2026EDGAR
4Mummert Mark RichardSep 16, 2026EDGAR
4Gagarinas Autumn M.Sep 16, 2026EDGAR

Insider trading

From Form 4 filings

All →
InsiderDateType
Wolff Alejandro DanielOct 1, 2026Grant / award
Mummert Mark RichardSep 14, 2026Grant / award
Gagarinas Autumn M.Sep 14, 2026Grant / award
Norris EricSep 14, 2026Grant / award
Hood MaxSep 1, 2026Grant / award

Top holders

13F & 13D/G • latest quarter

All →
HolderStakeFiledValue
Capital World Investors8.4%Aug 12, 2026$1.34B
BlackRock, Inc.8.1%Aug 7, 2026$1.28B
Vanguard Capital Management6.5%Aug 13, 2026$1.04B
Vanguard Portfolio Management5.5%Aug 13, 2026$869.18M
STATE STREET CORPORATION4.7%Sep 22, 2026$744.81M

ALB's filings are public. The insight is one click away.

Scrutar's AI reads every ALB filing and points out what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.

Analyze ALB filingsNo credit cardAI reports included on the free plan

Never miss a ALB filing.

Get an email when ALB files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.

Free foreverNo account requiredOne-click unsubscribe

Protected by reCAPTCHA. Privacy & Terms

Data as of Nov 8, 2026Source: SEC EDGAR.